<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Services — Leocyte</title>
  <meta name="description" content="Leocyte services: deal sourcing, diligence, licensing, regulatory partnerships, market access and commercialization across the pharma value chain." />
  <link rel="stylesheet" href="/assets/css/styles.css" />
  <script defer src="/cookie-consent.js"></script>
</head>
<body class="layout">
  <a class="skip" href="#main">Skip to main content</a>
  <header class="site-header">
    <div class="container">
      <a class="logo" href="/"><strong>Leocyte</strong></a>
      <nav aria-label="Main navigation">
        <ul class="nav">
          <li><a href="/about.html">About</a></li>
          <li><a href="/services.html" aria-current="page">Services</a></li>
          <li><a href="/markets.html">Markets</a></li>
          <li><a href="/privacy.html">Privacy</a></li>
        </ul>
      </nav>
      <a class="cta small" href="mailto:AlloAllo@leocyte.com">Talk to our market leads</a>
    </div>
  </header>

  <main id="main" class="container" role="main">
    <article>
      <h1>Services — Full value-chain BD&L</h1>
      <p class="lede">We operate across every stage where value is created in pharmaceuticals: discovery, clinical development, regulatory, manufacturing, distribution and commercialization. Our approach blends strategic rigor with local knowledge and measurable KPIs. :contentReference[oaicite:4]{index=4}</p>

      <section>
        <h2>1. Deal sourcing & opportunity screening</h2>
        <p>Targeted scouting using clinical filters, IP landscape, and market-fit scoring. We prioritize deals with clinical plausibility and scalable commercial potential.</p>
      </section>

      <section>
        <h2>2. Diligence & valuation</h2>
        <p>Clinical-readout scenario modelling, payer & pricing sensitivity analysis, and risk-adjusted valuation to inform term sheets.</p>
      </section>

      <section>
        <h2>3. Licensing & commercial structures</h2>
        <p>We design risk-sharing structures — exclusive licensing, co-development, royalties, milestones — with a focus on aligning incentives across partners and markets.</p>
      </section>

      <section>
        <h2>4. Regulatory & market access partnerships</h2>
        <p>Country-by-country market access playbooks: regulatory pathways, health-technology assessment expectations, reimbursement interactions and time-to-market planning.</p>
      </section>

      <section>
        <h2>5. Commercialization & launch strategy</h2>
        <p>Go-to-market planning, distributor selection, and performance KPIs to ensure sustained adoption and payer alignment.</p>
      </section>

      <section>
        <h2>6. Portfolio optimization & divestment</h2>
        <p>Lifecycle assessment and prioritization, plus exit planning when assets are better matched to other partners.</p>
      </section>

      <p class="muted small-note">We recommend an iterative, metrics-driven BD process (screen → validate → structure → execute → measure) to keep deal pipelines healthy and focused. For a framework aligned with industry best practice see BCG's "Six ways..." for building effective BD strategy. :contentReference[oaicite:5]{index=5}</p>
    </article>
  </main>

  <footer class="site-footer">
    <div class="container footer-grid">
      <div>
        <strong>Leocyte</strong><br/>
        Email: <a href="mailto:AlloAllo@leocyte.com">AlloAllo@leocyte.com</a>
      </div>
      <nav aria-label="Footer">
        <ul class="footer-nav"><li><a href="/privacy.html">Privacy</a></li></ul>
      </nav>
      <div class="small muted">© <span id="year3"></span> Leocyte — All rights reserved</div>
    </div>
  </footer>

  <script>document.getElementById('year3').textContent = new Date().getFullYear();</script>
</body>
</html>
